Yen's rise to 155 reignites carry-trade reversal speculation
A stronger yen is threatening the cheap-funding trade that global investors have leaned on for years - here's what an unwind would hit first.

Loading the region desk
Gathering coverage from this region…
Executive intelligence curated from Asia sources and global coverage.
68 briefings briefings in Asia
A stronger yen is threatening the cheap-funding trade that global investors have leaned on for years - here's what an unwind would hit first.
Nikkei reports early production is minuscule, signaling a tough road to launch and a possible supply crunch for buyers.
Berkshire Hathaway's stake in Japan's five trading houses is growing, and Itochu's chairman is signaling the door is open for more.
A tropical-Pacific event upgraded to 'very strong' is forecast to hold into late winter - here's the chain of impacts hitting food, power, and inflation across Asia.
The 'Trump whisperer' keeps his White House and Beijing access as Apple navigates tariffs and a $4.6 trillion market cap.
With a fractured opposition making a stable majority impossible, Tokyo's ruling party is quietly reviving its old tie-up - and that changes every boardroom's political risk calculus.
Japan's tech giant is signaling a strategic shift toward high-growth sectors, with an eye on manufacturer deals. Here's what it means for the competitive landscape.
Pacific leaders are pushing for urgent climate action as the 1.5C threshold, the Paris Agreement's most guarded line, moves closer to being breached.
The iconic off-roader returns after a decade, with Mitsubishi betting on Thailand's booming SUV market to lead a regional comeback.
The legendary off-roader returns as Mitsubishi bets on nostalgia and the booming SUV market to win back global buyers.
Governor Kazuo Ueda kept a rate hike on the table for all upcoming meetings, including the December one, as inflation and wage momentum turn into policy pressure.
Beijing's health regulators have approved a wave of brain-computer interface products this year, as domestic startups target paralysis, Alzheimer's, and depression - putting China in direct competition with Elon Musk's Neuralink.